Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases

MLA

Santini, D., et al. “Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases.” Current Cancer Drug Targets, vol. 9, no. 7, Nov. 2009, pp. 834–42. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs20202487&authtype=sso&custid=ns315887.

APA

Santini, D., Fratto, M., Vincenzi, B., Napoli, N., Galluzzo, S., Tantardini, M., Abbruzzese, A., Caraglia, M., & Tonini, G. (2009). Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases. Current Cancer Drug Targets, 9(7), 834–842.

Chicago

Santini, D., M. Fratto, B. Vincenzi, N. Napoli, S. Galluzzo, M. Tantardini, A. Abbruzzese, M. Caraglia, and G. Tonini. 2009. “Denosumab: The Era of Targeted Therapies in Bone Metastatic Diseases.” Current Cancer Drug Targets 9 (7): 834–42. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs20202487&authtype=sso&custid=ns315887.